The autosomal dominant form of CPVT has become the prototypical disease of RyR2-mediated arrhythmia, and accounts for at least half of all positive CPVT diagnoses (Priori et al., 2002). This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.